Master VA - Search Results

1

Major histocompatibility complex I upregulation in clear cell renal cell carcinoma is associated with increased survival.

Sekar RR, De La Calle CM, Patil D, Holzman SA, Baum Y, Sheikh U, Huang JH, Osunkoya AO, Pollack BP, Kissick HT, Ogan K, Master VA. Sekar RR, et al. Among authors: master va. Asian J Urol. 2016 Apr;3(2):75-81. doi: 10.1016/j.ajur.2016.02.001. Epub 2016 Feb 26. Asian J Urol. 2016. PMID: 29264168 Free PMC article.

2

Effects of obesity and weight loss in patients with nononcological urological disease.

Natarajan V, Master V, Ogan K. Natarajan V, et al. J Urol. 2009 Jun;181(6):2424-9. doi: 10.1016/j.juro.2009.01.107. Epub 2009 Apr 16. J Urol. 2009. PMID: 19371912 Review.

3

Leg endoscopic groin lymphadenectomy (LEG procedure): step-by-step approach to a straightforward technique.

Master V, Ogan K, Kooby D, Hsiao W, Delman K. Master V, et al. Eur Urol. 2009 Nov;56(5):821-8. doi: 10.1016/j.eururo.2009.07.003. Epub 2009 Jul 15. Eur Urol. 2009. PMID: 19640633

4

Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma.

Johnson TV, Abbasi A, Owen-Smith A, Young A, Ogan K, Pattaras J, Nieh P, Marshall FF, Master VA. Johnson TV, et al. Among authors: master va. J Urol. 2010 Feb;183(2):480-5. doi: 10.1016/j.juro.2009.10.014. Epub 2009 Dec 14. J Urol. 2010. PMID: 20006861

5

The impact of income and education on dietary habits in stone formers.

Saint-Elie DT, Patel PV, Healy KA, Solomon T, Pattaras JG, Qian J, Master VA, Ogan K. Saint-Elie DT, et al. Among authors: master va. Urology. 2010 Aug;76(2):307-13. doi: 10.1016/j.urology.2009.11.028. Epub 2010 Feb 6. Urology. 2010. PMID: 20138338

6

Feasibility of a novel approach to inguinal lymphadenectomy: minimally invasive groin dissection for melanoma.

Delman KA, Kooby DA, Ogan K, Hsiao W, Master V. Delman KA, et al. Ann Surg Oncol. 2010 Mar;17(3):731-7. doi: 10.1245/s10434-009-0816-7. Ann Surg Oncol. 2010. PMID: 20183910

7

Postoperative better than preoperative C-reactive protein at predicting outcome after potentially curative nephrectomy for renal cell carcinoma.

Johnson TV, Abbasi A, Owen-Smith A, Young AN, Kucuk O, Harris WB, Osunkoya AO, Ogan K, Pattaras J, Nieh PT, Marshall FF, Master VA. Johnson TV, et al. Among authors: master va. Urology. 2010 Sep;76(3):766.e1-5. doi: 10.1016/j.urology.2010.01.052. Epub 2010 Apr 14. Urology. 2010. PMID: 20394975

8

C-reactive protein as a clinically useful biomarker of metastasis of renal cell carcinoma.

Johnson TV, Young AN, Osunkoya AO, Master VA. Johnson TV, et al. Among authors: master va. Mol Diagn Ther. 2010 Jun 1;14(3):191-3. doi: 10.1007/BF03256373. Mol Diagn Ther. 2010. PMID: 20560682

9

Nocturia associated with depressive symptoms.

Johnson TV, Abbasi A, Ehrlich SS, Kleris RS, Raison CL, Master VA. Johnson TV, et al. Among authors: master va. Urology. 2011 Jan;77(1):183-6. doi: 10.1016/j.urology.2010.04.048. Urology. 2011. PMID: 20599253

10

Stage IV prostate cancer: survival differences in clinical T4, nodal and metastatic disease.

Hsiao W, Moses KA, Goodman M, Jani AB, Rossi PJ, Master VA. Hsiao W, et al. Among authors: master va. J Urol. 2010 Aug;184(2):512-8. doi: 10.1016/j.juro.2010.04.010. Epub 2010 Jun 17. J Urol. 2010. PMID: 20620410

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

398 results

Search Page

Filters